Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;18(7):e012524.
doi: 10.1161/CIRCHEARTFAILURE.124.012524. Epub 2025 May 16.

Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

Sasha Z Prisco  1 , Madelyn Blake  1 , Felipe Kazmirczak  1 , Ryan Moon  1 , Benjamin P Kremer  1 , Lynn M Hartweck  1 , Minwoo Kim  1 , Neal Vogel  1 , Jenna B Mendelson  1 , Daphne Moutsoglou  2   3 , Thenappan Thenappan  1 , Kurt W Prins  1
Affiliations

Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

Sasha Z Prisco et al. Circ Heart Fail. 2025 Jul.

Abstract

Background: Inflammation suppresses right ventricular (RV) function in pulmonary arterial hypertension (PAH). In particular, we showed GP130 (glycoprotein-130) signaling promotes pathological microtubule remodeling and RV dysfunction in rodent PAH. Emerging data demonstrate the intestinal microbiome regulates systemic inflammation, but the impact of modulating the gut microbiome on the GP130-microtubule axis in RV failure is unknown.

Methods: Two weeks following monocrotaline injection, rats were administered daily Lactobacillus rhamnosus (4×107 colony-forming units) via oral gavage for 10 days. Next-generation metagenomics and internal transcribed spacer 2 sequencing delineated fecal bacterial and fungal compositions. SomaScan proteomics measured levels of 7596 serum proteins. RV immunoblots quantified protein abundances. Light or super resolution confocal microscopy assessed RV, lung, and jejunal morphology. Echocardiography and invasive closed-chest pressure-volume loops evaluated PAH severity and RV function. The relationship between Lactobacillus abundance and RV function was assessed in 65 patients with PAH.

Results: Lactobacillus administration restructured both the intestinal micro- and mycobiome. The alteration in the gut ecosystem improved intestinal health as demonstrated by increased jejunal villus length and glycocalyx thickness and diminished intestinal permeability biomarkers. Serum proteomics revealed Lactobacillus modulated systemic inflammation and decreased circulating GP130 ligands. Lactobacillus-mediated suppression of GP130 signaling blunted pathological microtubule remodeling in RV cardiomyocytes. Microtubule-associated phenotypes, including RV cardiomyocyte and nuclear hypertrophy, transverse tubule integrity, and connexin-43 localization, were all corrected with Lactobacillus. These cellular changes manifested as improved RV function despite no significant alteration in PAH severity. Finally, patients with PAH and detectable fecal Lactobacillus had superior RV function despite similar mean pulmonary arterial pressure and pulmonary vascular resistance as compared with those without detectable Lactobacillus.

Conclusions: Lactobacillus supplementation restructures the gut micro/mycobiome, restores intestinal health, dampens systemic inflammation, and reduces GP130 ligands and associated RV cardiomyocyte microtubule remodeling. These data identify a novel microbiome-inflammation-microtubule axis that has therapeutic relevance for RV dysfunction.

Keywords: animals; ecosystem; hypertrophy; lung; phenotype.

PubMed Disclaimer

Conflict of interest statement

Dr Prisco reports personal fees from Merck. Dr Thenappan reports personal fees from Actelion, United Therapeutics, Altavant Sciences, Aria CV, GossimerBio, and Acceleron. Dr Prins received grant funding from Bayer. The other authors report no conflicts.

Comment in

References

    1. Prisco SZ, Thenappan T, Prins KW. Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension. JACC Basic Transl Sci. 2020;5:1244–1260. doi: 10.1016/j.jacbts.2020.07.011 - DOI - PMC - PubMed
    1. Khassafi F, Chelladurai P, Valasarajan C, Nayakanti SR, Martineau S, Sommer N, Yokokawa T, Boucherat O, Kamal A, Kiely DG, et al. Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension. Nature Cardiovascular Research. 2023;2:917–936. doi: 10.1038/s44161-023-00338-3 - DOI - PMC - PubMed
    1. Park JF, Clark VR, Banerjee S, Hong J, Razee A, Williams T, Fishbein G, Saddic L, Umar S. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of EMT in Human Right Ventricular Failure. Circ Heart Fail. 2021:Circheartfailure120007058. doi: 10.1161/circheartfailure.120.007058 - DOI - PMC - PubMed
    1. Hemnes AR, Celermajer DS, D’Alto M, Haddad F, Hassoun PM, Prins KW, Naeije R, Vonk Noordegraaf A. Pathophysiology of the right ventricle and its pulmonary vascular interaction. Eur Respir J. 2024;64. doi: 10.1183/13993003.01321-2024 - DOI - PMC - PubMed
    1. Prisco SZ, Hartweck LM, Rose L, Lima PDA, Thenappan T, Archer SL, Prins KW. Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility. Circ Heart Fail. 2022;15:e008574. doi: 10.1161/CIRCHEARTFAILURE.121.008574 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources